IP Library Granted Patent US 10,258,657
Granted Patent B2
US 10,258,657 · App. 15/509,002 · Granted Apr 16, 2019

Therapeutic and nutritional compositions for functional gastrointestinal disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,258,657
App. No.
15/509,002
Granted
Apr 16, 2019
Kind
B2
Abstract

The present invention relates to nutritional compositions containing balanced amount of substance having anti-inflammatory activity, as curcumin, and substance having carminative and spasmolytic activities, as essential plant oil, for the treatment and/or prevention of functional gastrointestinal disorders.

Claims (14)

1. A method of treating Irritable Bowel Syndrome (IBS) in a human in need thereof, said method comprising: orally administering to said human a nutritional composition consisting of curcumin in an amount from 10 to 200 mg and fennel essential oil in an amount from 5 to 50 mg together with pharmaceutical excipients, wherein the Irritable Bowel Syndrome total severity scores are between 100 and 300.

2. The method according to claim 1 , wherein the nutritional composition consists of curcumin in an amount from 20 to 100 mg and the fennel essential oil is in an amount from 15 to 35 mg.

3. The method according to claim 1 , wherein the nutritional composition consists of 42 mg curcumin, 600 mg polysorbate 80, 17.5 mg fennel essential oil and 3.5 mg citric acid in a gelatin capsule.

4. The method according to claim 1 , wherein the nutritional composition is administered at curcumin daily dosage from 10 to 3200 mg and fennel oil from 5 to 800 mg.

5. The method according to claim 4 , wherein the nutritional composition is administered at curcumin daily dosage from 20 to 1600 mg and fennel oil from 15 to 560 mg.

6. The method according to claim 4 , wherein the nutritional composition is administered at curcumin daily dosage from 40 to 800 mg and fennel oil from 15 to 400 mg.

7. The method according to claim 1 , wherein the nutritional composition is administered for a period of time of at least 10 days.

8. The method according to claim 7 , wherein the nutritional composition is administered for a period of time between 10 and 30 days.

9. A method of preparing a nutritional composition consisting of curcumin in an amount from 10 to 200 mg and fennel essential oil in an amount from 5 to 50 mg together with pharmaceutical excipients, said method comprising the steps of:

mixing curcumin with citric acid and polysorbate 80 and stirring until a homogenous mixture is formed;

adding fennel essential oil under stirring and loading the formed homogenous mixture into a gelatin capsule;

wherein the fennel essential oil is 2.5% by weight of the nutritional composition.

10. The method according to claim 1 , wherein the nutritional composition is administered in functional food, aqueous solution, beverage, solid or semisolid food.

11. A kit system comprising a nutritional composition consisting of curcumin in an amount from 10 to 200 mg and fennel essential oil in an amount from 5 to 50 mg together with pharmaceutical excipients in the form of a gelatin capsule; wherein the fennel essential oil is 2.5% by weight of the nutritional composition.

Assignments (3)
CHANGE OF ADDRESS Recorded Nov 16, 2018
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 047586/0833 →
MERGER Recorded Nov 14, 2017
From: ALFA WASSERMANN S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 045061/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2017
From: GRIMALDI, MARIA; FOGLI, MARIA VITTORIA; VISCOMI, GIUSEPPE CLAUDIO
To: ALFA WASSERMANN S.P.A.
Reel/Frame 041483/0731 →